剖宫产时布比卡因脂质体切口阻滞减少术后疼痛:一项随机对照试验
在择期剖宫产未使用过阿片类药物的女性中,单盲随机对照试验将布比卡因脂质体或安慰剂浸润于手术部位筋膜和皮肤。主要结局为术后48小时活动时疼痛评分,两组相似(P=.72);术后48小时阿片类药物用量两组亦相似(P=.44)。
要点
- 布比卡因脂质体切口阻滞组术后48小时活动时疼痛评分中位数4分,安慰剂组3.5分(P=.72)。
- 布比卡因脂质体组术后48小时阿片类药物用量中位数37.5吗啡毫克当量,安慰剂组37.5吗啡毫克当量(P=.44)。
- 与安慰剂相比,剖宫产时布比卡因脂质体切口阻滞术后48小时内疼痛评分相似。
核心结论
- 与安慰剂相比,剖宫产时布比卡因脂质体切口阻滞在术后48小时内产生相似的疼痛评分。
研究设计与样本
- 单盲随机对照试验,纳入未使用过阿片类药物的剖宫产女性,在筋膜闭合前将布比卡因脂质体或安慰剂浸润于手术部位筋膜和皮肤。
- 2017年3月至9月筛查249名女性,入组103名,随机化80名;布比卡因脂质体组1名因垂直皮肤切口被排除,最终布比卡因脂质体组39例、安慰剂组40例。
- 每组需40名女性以检测干预组疼痛评分降低1.5分。
主要发现
- 术后48小时活动时疼痛评分中位数(四分位距):布比卡因脂质体组4(2-5) vs 安慰剂组3.5(2-5.5),P=.72。
- 术后前48小时阿片类药物用量中位数(四分位距):布比卡因脂质体组37.5(7.5-60)吗啡毫克当量 vs 安慰剂组37.5(15-75)吗啡毫克当量,P=.44。
- 两组基线特征相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether a liposomal bupivacaine incisional block decreases postoperative pain and represents an opioid-minimizing strategy after scheduled cesarean delivery. METHODS: In a single-blind, randomized controlled trial among opioid-naive women undergoing cesarean delivery, liposomal bupivacaine or placebo was infiltrated into the fascia and skin at the surgical site, before fascial closure. Using an 11-point numeric rating scale, the primary outcome was pain score with movement at 48 hours postoperatively. A sample size of 40 women per group was needed to detect a 1.5-point reduction in pain score in the intervention group. Pain scores and opioid consumption, in oral morphine milligram equivalents, at 48 hours postoperatively were summarized as medians (interquartile range) and compared using the Wilcoxon rank-sum test. RESULTS: Between March and September 2017, 249 women were screened, 103 women enrolled, and 80 women were randomized. One woman in the liposomal bupivacaine group was excluded after randomization as a result of a vertical skin incision, leaving 39 patients in the liposomal bupivacaine group and 40 in the placebo group. Baseline characteristics between groups were similar. The median (interquartile range) pain score with movement at 48 hours postoperatively was 4 (2-5) in the liposomal bupivacaine group and 3.5 (2-5.5) in the placebo group (P=.72). The median (interquartile range) opioid use was 37.5 (7.5-60) morphine milligram equivalents in the liposomal bupivacaine group and 37.5 (15-75) morphine milligram equivalents in the placebo group during the first 48 hours postoperatively (P=.44). CONCLUSION: Compared with placebo, a liposomal bupivacaine incisional block at the time of cesarean delivery resulted in similar postoperative pain scores in the first 48 hours postoperatively. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02959996.
引用
- Prabhu M, Clapp MA, McQuaid-Hanson E, et al. Liposomal Bupivacaine Block at the Time of Cesarean Delivery to Decrease Postoperative Pain: A Randomized Controlled Trial. Obstet Gynecol. 2018. PMID: 29889750. doi:10.1097/AOG.0000000000002649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。